Karen Prange - Net Worth and Insider Trading

Karen Prange Net Worth

The estimated net worth of Karen Prange is at least $4 Million dollars as of 2024-11-09. Karen Prange is the SVP&Pres, Uro & Pelvic Health of Boston Scientific Corp and owns about 39,395 shares of Boston Scientific Corp (BSX) stock worth over $3 Million. Karen Prange is the Director of AtriCure Inc and owns about 16,140 shares of AtriCure Inc (ATRC) stock worth over $604,443. Karen Prange is also the Director of ViewRay Inc and owns about 8,799 shares of ViewRay Inc (VRAYQ) stock worth over $0. Details can be seen in Karen Prange's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Karen Prange has not made any transactions after 2023-07-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Karen Prange

To

Karen Prange Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Karen Prange owns 7 companies in total, including Cantel Medical Corp (CMD) , AtriCure Inc (ATRC) , and Nevro Corp (NVRO) among others .

Click here to see the complete history of Karen Prange’s form 4 insider trades.

Insider Ownership Summary of Karen Prange

Ticker Comapny Transaction Date Type of Owner
CMD Cantel Medical Corp 2020-07-31 director
ATRC AtriCure Inc 2023-06-08 director
NVRO Nevro Corp 2019-12-17 director
LIMIT LIMIT 2016-05-17 EVP&CEO Gl.AH.Med.Den.Sur.Grp
LIMIT LIMIT 2016-03-08 SVP&Pres & Uro & Women's Health
LIMIT LIMIT 2023-07-21 director
LIMIT LIMIT 2022-04-01 director

Karen Prange Latest Holdings Summary

Karen Prange currently owns a total of 3 stocks. Among these stocks, Karen Prange owns 39,395 shares of Boston Scientific Corp (BSX) as of March 8, 2016, with a value of $3 Million and a weighting of 85.19%. Karen Prange owns 16,140 shares of AtriCure Inc (ATRC) as of June 8, 2023, with a value of $604,443 and a weighting of 14.81%. Karen Prange also owns 8,799 shares of ViewRay Inc (VRAYQ) as of July 21, 2023, with a value of $0 and a weighting of 0%.

Latest Holdings of Karen Prange

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BSX Boston Scientific Corp 2016-03-08 39,395 88.25 3,476,609
ATRC AtriCure Inc 2023-06-08 16,140 37.45 604,443
VRAYQ ViewRay Inc 2023-07-21 8,799 0.00 0

Holding Weightings of Karen Prange


Karen Prange Form 4 Trading Tracker

According to the SEC Form 4 filings, Karen Prange has made a total of 0 transactions in Boston Scientific Corp (BSX) over the past 5 years. The most-recent trade in Boston Scientific Corp is the sale of 14,747 shares on March 8, 2016, which brought Karen Prange around $254,681.

According to the SEC Form 4 filings, Karen Prange has made a total of 1 transactions in AtriCure Inc (ATRC) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in AtriCure Inc is the sale of 713 shares on June 8, 2023, which brought Karen Prange around $34,146.

According to the SEC Form 4 filings, Karen Prange has made a total of 2 transactions in ViewRay Inc (VRAYQ) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in ViewRay Inc is the sale of 129,466 shares on July 21, 2023, which brought Karen Prange around $7,768.

Insider Trading History of Karen Prange

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Karen Prange Trading Performance

GuruFocus tracks the stock performance after each of Karen Prange's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Karen Prange is 32.95%. GuruFocus also compares Karen Prange's trading performance to market benchmark return within the same time period. The performance of stocks bought by Karen Prange within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Karen Prange's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Karen Prange

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 6.9 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 9.4 LIMIT LIMIT LIMIT LIMIT LIMIT

Karen Prange Ownership Network

Ownership Network List of Karen Prange

No Data

Ownership Network Relation of Karen Prange

Insider Network Chart

Karen Prange Owned Company Details

What does Cantel Medical Corp do?

Who are the key executives at Cantel Medical Corp?

Karen Prange is the director of Cantel Medical Corp. Other key executives at Cantel Medical Corp include director & 10 percent owner & Chairman Charles M Diker , director & Chief Executive Officer George L Fotiades , and Executive Vice President Seth M Yellin .

Cantel Medical Corp (CMD) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Cantel Medical Corp (CMD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cantel Medical Corp (CMD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Cantel Medical Corp (CMD)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cantel Medical Corp Insider Transactions

No Available Data

Karen Prange Mailing Address

Above is the net worth, insider trading, and ownership report for Karen Prange. You might contact Karen Prange via mailing address: 1108 S Rio Vista Blvd, Fort Lauderdale Fl 33316.